191 related articles for article (PubMed ID: 34074603)
41. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
[TBL] [Abstract][Full Text] [Related]
42. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
Mundangepfupfu T; Waseem M
J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
[TBL] [Abstract][Full Text] [Related]
43. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
Boyko WL; Russell HT
Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
[TBL] [Abstract][Full Text] [Related]
44. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
Norman RJ; Buck RH; Joubert SM
S Afr Med J; 1989 Apr; 75(7):318-9. PubMed ID: 2538933
[TBL] [Abstract][Full Text] [Related]
45. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
[TBL] [Abstract][Full Text] [Related]
46. Qualitative and quantitative analysis of diffusion-weighted imaging of gestational trophoblastic disease: Can it predict progression of molar pregnancy to persistent form of disease?
Sefidbakht S; Hosseini F; Bijan B; Hamedi B; Azizi T
Eur J Radiol; 2017 Mar; 88():71-76. PubMed ID: 28189211
[TBL] [Abstract][Full Text] [Related]
47. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
[TBL] [Abstract][Full Text] [Related]
48. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
49. Inappropriate management of women with persistent low hCG results.
Cole LA; Khanlian SA
J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
[TBL] [Abstract][Full Text] [Related]
50. Update on the diagnosis and management of gestational trophoblastic disease.
Ngan HYS; Seckl MJ; Berkowitz RS; Xiang Y; Golfier F; Sekharan PK; Lurain JR; Massuger L
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():79-85. PubMed ID: 30306586
[TBL] [Abstract][Full Text] [Related]
51. A case of a hydatidiform mole in a 56-year-old woman.
Lok CA; Zürcher AF; van der Velden J
Int J Gynecol Cancer; 2005; 15(1):163-6. PubMed ID: 15670312
[TBL] [Abstract][Full Text] [Related]
52. Pathology of gestational trophoblastic diseases.
Cheung AN
Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):849-68. PubMed ID: 14614885
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53.
Soper JT; Mutch DG; Schink JC;
Gynecol Oncol; 2004 Jun; 93(3):575-85. PubMed ID: 15196847
[TBL] [Abstract][Full Text] [Related]
54. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
55. Levels of placenta growth factor in gestational trophoblastic diseases.
Okamoto T; Niu R; Mizutani S; Yamada S
Am J Obstet Gynecol; 2003 Jan; 188(1):135-40. PubMed ID: 12548207
[TBL] [Abstract][Full Text] [Related]
56. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
[TBL] [Abstract][Full Text] [Related]
58. [Survey of gestational trophoblastic disease incidence among 3.6 million pregnancies in China].
Shi YF; Li JQ; Zheng W; Chen XJ; Qiao YH; Hao M; Zhou CW; Hu YL; Wan GM; Sha YC; Zheng X
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):76-8. PubMed ID: 15840282
[TBL] [Abstract][Full Text] [Related]
59. Dysregulated activation of c-Src in gestational trophoblastic disease contributes to its aggressive progression.
Wu W; Wang Y; Xu Y; Liu Y; Wang Y; Zhang H
Placenta; 2014 Oct; 35(10):824-30. PubMed ID: 25108485
[TBL] [Abstract][Full Text] [Related]
60. [Gestational trophoblastic disease, Villous gestational trophoblastic disease].
Vogel M; Horn LC
Pathologe; 2004 Jul; 25(4):269-79. PubMed ID: 15197483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]